Two unrelated Japanese women, 41 and 27 years of age, were admitted with histories of thirst, weight loss and palpitations of a few weeks' duration. Both were diagnosed to have diabetic ketosis or ketoacidosis with acute-onset type 1 diabetes (T1D) and Graves' disease (GD) (autoimmune polyglandular syndrome type 3 variant; APS3v), and were treated with intensive insulin therapy and anti-thyroid drugs. Human leukocyte antigen examinations showed that both cases had the HLA-A2, A24, B54, and DRB1*04:05-DQA1*03:03-DQB1*04:01 haplotype, which made them susceptible not only to APS3v, but also to both acute-onset T1D and GD. The genetic background of patients strongly contributes to the simultaneous occurrence of T1D and GD.
Introduction
Type 1 diabetes mellitus (T1D) and autoimmune thyroid disease (AITD) are common autoimmune endocrine diseases, and the occurrence of both T1D and AITD in the same patient is defined as autoimmune polyglandular syndrome type 3 variant (APS3v) (1) . Epidemiological evidence suggests that there are overlapping genetic backgrounds for APS3v (T1D and AITD). Among T1D subjects, 15% to 30% have AITD (Graves' disease and/or Hashimoto's thyroiditis) (2) .
Graves' disease (GD) was reported to be present in 6.3% of patients with T1D (acute-onset T1D and slowly progressive T1D), 2.9% with acute-onset T1D, 13.0% with slowly progressive T1D and 0.4% with type 2 diabetes mellitus (T2D) in a Japanese outpatient clinic (3) . However, the simultaneous occurrence of acute-onset T1D and GD is rare. We herein report the cases of two patients with APS3v who developed acute-onset T1D and GD almost simultaneously.
We also present the characteristic human leukocyte antigen (HLA) typing results for both cases. In addition, we review the relevant literature on the clinical and genetic characteristics of Japanese patients with APS3v, in whom T1D and GD were both diagnosed or developed simultaneously.
Case Reports

Case 1
A 41-year-old Japanese woman was hospitalized with a two-week history of thirst, palpitations and a five kilogram weight loss. One month prior to admission, she had visited a clinic for cystitis. At that time, her plasma glucose and HbA1c (NGSP) levels were 92 mg/dL and 7.5%, respectively. Her past medical history was unremarkable, but her mother and a maternal uncle had T2D. On admission, she was 155 cm in height and weighed 35 kg (body mass index: 14.6 kg/m 2 ). Her blood pressure was 143/52 mmHg, her pulse was regular at 104 beats/min and her temperature was 37.1 . Neither exophthalmos nor diabetic retinopathy was observed. A diffuse goiter was palpable. There were no abnormal findings of the heart, lungs or abdomen. Neurological examinations revealed no abnormalities except for finger tremors and a slightly brisk relaxation phase of the Achilles tendon reflex.
The laboratory data obtained on admission are shown in Table 1 . The plasma glucose and HbA1c levels were markedly elevated, and both the serum and urine showed increased ketone bodies. Her arterial blood gas data showed a tendency toward metabolic acidosis, with an increased anion gap. The serum and urinary C-peptide levels were remarkably decreased. She was positive for anti-glutamic acid decarboxylase (GAD), insulinoma associated antigen-2 (IA-2) and insulin autoantibodies. Her serum levels of free thyroxine (FT4) and free triiodothyronine (FT3) were elevated, while her serum thyrotropin (TSH) level was suppressed. The patient was positive not only for TSH-binding inhibitor immunoglobulin (TBII) and thyroid-stimulating antibodies (TSAb), but also for anti-thyroid peroxidase antibodies (TPOAb) and anti-thyroglobulin antibodies (TgAb). The 99m TcO4 uptake into the thyroid gland was not decreased (3.4%). Ultrasonography revealed a diffusely swollen thyroid gland with heterogeneously low echogenicity. The serum levels of creatine kinase and creatinine were decreased. The chest X-ray findings were normal. Electrocardiography revealed sinus tachycardia. Based on the above results, the patient was diagnosed to have pre-ketoacidosis with acuteonset T1D and GD.
Intensive insulin therapy (maximum total 1.9 units/kg/ day) was initiated, and the diabetic ketosis disappeared quickly and her blood glucose control showed improvement. Treatment with thiamazole (15 mg/day) and potassium iodide (50 mg/day) relieved the thyrotoxicosis. Currently, five years after her first visit, she continues intensive insulin therapy (total 0.7 units/kg/day) for her T1D. However, she is in remission from Graves' disease, and has remained euthyroid without anti-thyroid drugs for two years, to date. 
Case 2
A 27-year-old Japanese woman was hospitalized with a one-month history of nausea and dizziness, as well as thirst and polyuria of a few weeks' duration and a five kilogram weight loss. She had undergone an artificial abortion six months prior to admission. Her mother and a maternal aunt had GD, and her father had T2D. On admission, she was 159 cm in height and weighed 47 kg (body mass index: 18.6 kg/m 2 ). Her blood pressure was 90/40 mmHg, her pulse was regular at 164 beats/min and her temperature was 37.1 . Mild exophthalmos was observed. Ophthalmological examinations revealed no signs of diabetic retinopathy. A diffuse goiter was palpable without tenderness. There were no abnormal findings of the heart, lungs or abdomen. Neurological examinations revealed no abnormalities except for finger tremors and a brisk relaxation phase of the Achilles tendon reflex.
The laboratory data obtained on admission are shown in Table 1 . The plasma glucose, HbA1c, and glycoalbumin levels were markedly elevated. An arterial blood gas analysis and marked excretion of urinary ketone bodies indicated ketoacidosis. The serum and urinary C-peptide levels were remarkably decreased. She was positive for both GAD and IA-2 antibodies. Her serum levels of FT4 and FT3 were elevated, while the serum TSH level was suppressed. The patient was positive for not only TBII and TSAb, but also TPOAb and TgAb. The 99m TcO4 uptake into the thyroid gland was markedly elevated (27.0%). Ultrasonography revealed a diffusely swollen thyroid with low echogenicity. The serum results indicated volume depletion and mild hyponatremia. Her serum levels of alanine aminotransferase and alkaline phosphatase were slightly elevated. The chest X-ray was normal, while electrocardiography revealed sinus tachycardia. Based on the above results, the patient was diagnosed to have ketoacidosis with acute-onset T1D and GD.
After intravenous infusions of fluids and insulin, intensive insulin therapy (maximum total 1.1 units/kg/day) was initiated. The diabetic ketoacidosis disappeared within two days, and the blood glucose control was improved. Treatment with thiamazole (30 mg/day) relieved the symptoms of thyrotoxicosis. Two years after her first visit, she underwent subtotal thyroidectomy for Graves' hyperthyroidism, which was followed by subclinical hypothyroidism. She continues intensive insulin therapy (total 0.7 units/kg/day) for T1D. 
Discussion
T1D and GD apparently developed almost simultaneously in the present patients. Horie et al. (4) reported the chronological order of T1D and GD development in 30 Japanese patients with APS3v. Ten percent developed T1D and GD simultaneously, 60% developed GD before the onset of T1D and 30% developed GD after the onset of T1D. According to a report on 10 Japanese patients with APS3v published by Osaki et al (3) , GD preceded T1D in nine patients and T1D preceded GD in the other patient. Especially, in the three acute-onset T1D patients with GD, GD preceded diabetes in two of the patients, while T1D preceded GD in the other (3) . Therefore, the simultaneous occurrence of T1D and GD is relatively rare.
Hyperthyroidism appears not only to have further increased the plasma glucose level, but also to have aggravated the diabetic ketosis or ketoacidosis in the present patients. Hyperthyroidism increases the intestinal glucose absorption and hepatic glucose output due to increased hepatic glycogenolysis and gluconeogenesis, and decreases the peripheral insulin sensitivity (5). The glomerular filtration rate increased by hyperthyroidism leads to increased insulin clearance, and hence, decreases the insulin level (6) . Ketone body production in the liver is facilitated by the pronounced lipolytic effects and increased hepatic beta-oxidation, which are associated with hyperthyroidism (7). Thus, hyperthyroidism worsens the glycemic control and facilitates ketosis or ketoacidosis in patients with pre-existing diabetes with diminished insulin secretion.
The present female patients developed acute-onset T1D.
Their GAD antibody and IA-2 antibody titers were high, and their urinary excretion of C-peptide was markedly decreased. With regard to the clinical characteristics of APS3v (including both patients with T1D plus GD and those with T1D plus Hashimoto's thyroiditis), marked female predominance, a slowly progressive clinical course with older T1D onset age, a higher prevalence of GAD antibodies and a higher level of GAD antibodies were observed in APS3v patients compared to T1D patients without AITD (4, 8) . The prevalence of IA-2 antibodies was significantly higher in acute-onset T1D than in slowly progressive T1D among APS3v patients (4). Although both genetic and environmental factors play a role in the development of T1D and GD, the genetic background is a particularly strong factor in APS3v. The most important disease susceptibility genes are HLA genes (1), although non-HLA genes also contribute to the susceptibility to APS3v, such as cytotoxic T lymphocyte antigen 4 (CTLA4), protein tyrosine phosphatase nonreceptor type 22 (PTPN22) and forkhead box P3 (FOXP3), which are involved in the immunological synapse and T-cell regulation (1). Substantial ethnic differences exist in some genetic factors for APS3v due to the genetic heterogeneity among populations (9) .
The shared HLA types of the present two patients were A2, A24 and B54 for the class I antigen, and the DRB1* 04:05-DQA1*03:03-DQB1*04:01 haplotype for the class II antigen ( Table 2 ). We performed a literature search using PubMed (for English literature) and Ichushi (for Japanese reports listed by the non-profit Japan Medical Abstracts Society). Twenty-four reports (excluding meeting abstracts, fulminant T1D cases (10) and cases without descriptions of the HbA1c or GAD levels) on Japanese APS3v (T1D and GD) patients with HLA typing, whose T1D and GD had developed or been diagnosed simultaneously, have been reported in the English or Japanese language literature since 1990 (Table 2, 3). The age of these patients ranged from seven to 72 years (mean 37±19 years), and there were 24 women and seven men. The HLA typing of 50 unrelated healthy parents randomly selected from 701 Japanese families were used as controls (Table 3) , and were provided by the HLA Foundation Laboratory, Kyoto, Japan. The HLA types of the present two patients are not specific for the simultaneous occurrence of T1D and GD, but relatively restricted alleles and haplotypes are predominantly involved in the simultaneous occurrence of T1D and GD. The frequencies of HLA-B54, B61, DR4, DR9, DRB1*04:05, DRB1*09:01, DQB1*04:01 and DQB1*03:03 in reported APS3v cases, whose T1D and GD had developed or been diagnosed simultaneously, were significantly higher than those in the general Japanese population. The differences in the statistical significance of the frequencies between phenotypes and genotypes among DRB1*09:01 and DQB1*03:03, as well as among B54 and B61, are attributable to the high frequencies of homozygotes in DRB1*09:01 and DQB1*03:03 and heterozygotes in B54 and B61. Table 2 
Frequencies of antigen or allele Control
Frequencies of antigen or allele in Japanese among reported cases of T1D and GD in Table 2 With regard to HLA class I and T1D, the present two patients had HLA-A24 and B54 for the class I antigen. HLA-A24, B54, and B61 are significantly associated with T1D in Japanese patients (11) (12) (13) . While HLA-A24 is the most frequent allele at the HLA-A locus, HLA-A24 is implicated in promoting the destruction of pancreatic β cells (11) . There is strong linkage disequilibrium between the HLA-B54 and DRB1*04:05 alleles (12) . A remarkable increase in the odds ratio (OR) for developing T1D was observed in the population carrying both the DRB1*04:05 and the B54 allele (OR= 8.5) (13). The HLA-B61 allele is also in linkage disequilibrium with the DRB1*09:01 allele, one of the major T1D-related class II alleles (12) .
For HLA class II and APS3v, HLA-DRB1*04:05-DQB1* 04:01, DRB1*09:01-DQB1*03:03 and DRB1*08:02-DQB1* 03:02 are considered to be the three major susceptibility HLA haplotypes for T1D in the Japanese population. The alleles and haplotypes associated with acute-onset and those associated with slowly progressive T1D are similar (14) . Hashimoto et al. (15) reported that the characteristics of susceptibility HLA haplotypes differed among patients with APS3v (T1D and GD), T1D alone and GD alone. GD) and T1D alone. The frequencies of DRB1* 09:01 and DQB1*03:03 in the previously reported APS3v cases in which T1D and GD had either developed or been diagnosed simultaneously were higher than the frequencies in the 11 Japanese APS3v (T1D and GD) patients reported by Hashimoto et al. (15) , but the difference in DRB1*09:01 was not statistically significant ( Table 3 ). The risk of the simultaneous occurrence of T1D and GD might be higher in APS3v patients with HLA DRB1*09:01-DQB1*03:03 than in those with DRB1*04:05-DQB1*04:01. Since the number of reported cases of T1D and GD in Table 2 and those reported by Hashimoto et al. are small, larger number of cases will need to be accumulated to verify the above conclusions.
The genetic association of HLA is not as strong with GD as it is with T1D. Case 1 in the present report had HLA-A2, while Case 2 had HLA-A2 and DPB1*05:01 ( Table 2 ). Four of five reported patients had HLA-DPB1*05:01 (Table 3) . HLA-A2 and HLA-DPB1*05:01 are both reportedly factors conferring susceptibility to GD in Japanese patients. DPB1* 05:01-positive A2-negative and DPB1*05:01-negative A2-positive individuals exhibited OR of 4.4 and 2.2, respectively (16) . The OR (10.5) for developing Graves' disease is high in individuals with both DPB1*05:01 and HLA-A2 (16) .
The genetic and environmental differences between the simultaneous occurrence of T1D plus GD and the heterochronic occurrence of T1D and GD remain to be elucidates. With regard to the pathogenic mechanisms that contribute to the development of APS3v, there are several hypothetical mechanisms by which HLA could be involved in a common etiology of T1D and AITD (1, 9) . First, some HLA susceptibility alleles for T1D might be in tight linkage disequilibrium with that for AITD. Second, the HLA class II molecules might share a similar HLA pocket structure, fitting both islet cell peptides and thyroidal peptides (17) . On the other hand, GAD might contribute to the association between T1D and GD, because of the presence of GAD activity in the thyroid (8) and the relationship not only between GAD antibody and T1D, but also between GAD antibody and GD. A high-titer of GAD antibody is associated with the development of AITD in patients with T1D (18) . Conversely, AITD patients (particularly GD patients) with a high titer of GAD antibody and/or who were positive for both GAD and IA-2 antibodies are prone to develop T1D (19) .
In conclusion, we have described two Japanese women with APS3v, in whom acute-onset T1D and GD developed almost simultaneously. These two women were found to be genetically susceptible to not only APS3v (T1D and GD), but also to both acute-onset T1D and GD. The genetic background makes a contribution to the simultaneous occurrence of acute-onset T1D and GD in patients with APS3v.
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